Experts endorse low-sodium salt substitutes to cut India’s hypertension burden

Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk

Lupin receives USFDA approval for mixed salts of a single-entity amphetamine ER capsules

The product will be manufactured at Lupin’s Somerset facility in the US

Colgate Active Salt redefines oral hygiene with a new and improved formula

Granules Pharmaceuticals receives ANDA approval for amphetamine mixed salts ER capsules

Granules now have a total of 53 ANDA approvals from USFDA

Granules receives ANDA approval for amphetamine mixed salts

The current annual U.S. market for amphetamine mixed salts, USP 1.25mg, 1.875mg, 2.5mg, 3.125mg, 3.75mg, 5mg, 7.5mg immediate release tablets strengths is approximately US $ 335 million, according to MAT, Oct 2021 IQVIA/IMS Health

AbbVie seeks FDA nod for RINVOQ use in severe alopecia areata

After Phase 3 results show major hair regrowth gains

GPT Healthcare partners with MedLern to drive workforce upskilling and digital transformation at ILS Hospitals

AI-enabled learning platform to enhance clinical quality, patient outcomes, and staff engagement across Eastern India network

India pushes policy action on adolescent nutrition as obesity concerns rise

ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments

GPT Healthcare reports 12% revenue growth in 9M FY26, strengthens clinical capabilities

The company maintained a competitive ARPOB while steadily improving occupancy, driven by higher patient volumes and efficient capacity utilization

Niagen Bioscience secures full ownership of key NAD+ patents in major IP move

The portfolio includes foundational patents on the production, composition, and commercial use of NR